Skip to main content
Log in

Perioperative β-Rezeptoren-Blockade

Für und Wider

Perioperative beta-receptor blockade

For and against

  • Klinische Pharmakologie
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

Neuere Untersuchungen haben die Applikation von β-Rezeptoren-Blockern zur Senkung der perioperativen Morbiditäts- und Letalitätsrate infrage gestellt. Dies gilt besonders für Patienten, die kein oder nur ein geringes Risiko für ein kardiales Ereignis aufweisen. Nachdem Ende der 1990er Jahre die β-Rezeptoren-Blockertherapie als Standard angesehen wurde, zeigt die Datenlage selbst für Risikopatienten derzeit keine sichere Evidenz für eine solche Therapieinitiierung in der perioperativen Phase. Zudem treten gerade bei Patienten mit niedrigem kardialen Risiko die Nebenwirkungen einer β-Rezeptoren-Blockertherapie, die selbst zu einer Erhöhung der Morbiditätsrate beitragen können, in den Vordergrund.

Abstract

Results from recent studies have questioned the application of beta-receptor blockers for reduction of morbidity and mortality during the perioperative period. This holds true especially for patients with no or only low cardiac risk. Although beta-receptor blockade was a form of standard therapy at the end of the 1990s, data today show no clear evidence for such a therapy not even in patients at risk for cardiac events. At least in patients with low risk the initiation of beta-receptor blockade during the perioperative period might lead to side-effects, thereby increasing morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Bangalore S, Wetterslev J, Pranesh S et al (2008) Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 372:1962–1976

    Article  CAS  PubMed  Google Scholar 

  2. Beattie WS, Wijeysundera DN, Karkouti K et al (2008) Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 106:1039–1048

    Article  CAS  PubMed  Google Scholar 

  3. Biccard BM, Sear JW, Foex P (2008) Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes. Br J Anaesth 100:23–28

    Article  CAS  PubMed  Google Scholar 

  4. Blomqvist I, Westergren G, Sandberg A et al (1988) Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol. Eur J Clin Pharmacol 33:S19–S24

    Article  CAS  PubMed  Google Scholar 

  5. Boersma E, Kertai MD, Schouten O et al (2005) Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118:1134–1141

    Article  PubMed  Google Scholar 

  6. Brady AR, Gibbs JS, Greenhalgh RM et al (2005) Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41:602–609

    Article  CAS  PubMed  Google Scholar 

  7. Carson PE (1999) Beta blocker treatment in heart failure. Prog Cardiovasc Dis 41:301–321

    Article  CAS  PubMed  Google Scholar 

  8. Chen ZM, Pan HC, Chen YP et al (2005) Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 366:1622–1632

    Article  CAS  PubMed  Google Scholar 

  9. CIBIS-II Investigators and Committees (1999) The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial. Lancet 353:9–13

    Article  Google Scholar 

  10. Cohen MC, Aretz TH (1999) Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 8:133–139

    Article  CAS  PubMed  Google Scholar 

  11. Dahlof B, Sever PS, Poulter NR et al (2005) Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366:359–365

    Article  Google Scholar 

  12. Dandona P, Ghanim H, Brooks DP (2007) Antioxidant activity of carvedilol in cardiovascular disease. J Hypertens 25:731–741

    Article  CAS  PubMed  Google Scholar 

  13. Dawood MM, Gutpa DK, Southern J et al (1996) Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 57:37–44

    Article  CAS  PubMed  Google Scholar 

  14. Devereaux PJ, Beattie WS, Choi PT et al (2005) How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 331:313–321

    Article  CAS  PubMed  Google Scholar 

  15. Dunkelgrun M, Boersma E, Schouten O et al (2009) Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 249:921–926

    Article  PubMed  Google Scholar 

  16. Eagle KA, Berger PB, Calkins H et al (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery – executive summary a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 105:1257–1267

    PubMed  Google Scholar 

  17. Feringa HH, Bax JJ, Boersma E et al (2006) High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 114:I-344–I-349

    Article  Google Scholar 

  18. Fleischmann KE, Beckman JA, Buller CE et al (2009) ACCF/AHA focused update on perioperative beta blockade: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 120:2123–2151

    Article  PubMed  Google Scholar 

  19. Fleisher LA, Beckman JA, Brown KA et al (2009) ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 120:e169–e276

    Article  PubMed  Google Scholar 

  20. Fleisher LA, Beckman JA, Brown KA et al (2007) ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116:e418–e499

    Article  PubMed  Google Scholar 

  21. Fleisher LA, Beckman JA, Brown KA et al (2006) ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation 113:2662–2674

    Article  PubMed  Google Scholar 

  22. Gottlieb SS, McCarter RJ, Vogel RA (1998) Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339:489–497

    Article  CAS  PubMed  Google Scholar 

  23. Hansson L, Hedner T, Lund-Johansen P et al (2000) Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic diltiazem (NORDIL) study. Lancet 356:359–365

    Article  CAS  PubMed  Google Scholar 

  24. Hoeks SE, Scholte op Reimer WJM, Urk H van et al (2007) Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. Eur J Vasc Endovasc Surg 33:13–19

    Article  CAS  PubMed  Google Scholar 

  25. Juul AB, Wetterslev J, Gluud C et al (2006) Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332:1482

    Article  PubMed  Google Scholar 

  26. Landesberg G (2003) The pathophysiology of perioperative myocardial infarction: facts and perspectives. J Cardiothorac Vasc Anesth 17:90–100

    Article  PubMed  Google Scholar 

  27. Landesberg G (2005) Monitoring for myocardial ischemia. Best Pract Res Clin Anaesthesiol 19:77–95

    PubMed  Google Scholar 

  28. Le Manach Y, Perel A, Coriat P et al (2005) Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 102:885–891

    Article  Google Scholar 

  29. Lee TH, Marcantonio ER, Mangione CM et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049

    CAS  PubMed  Google Scholar 

  30. Lindenauer PK, Pekow P, Wang K et al (2005) Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353:349–361

    Article  CAS  PubMed  Google Scholar 

  31. Mangano DT, Layug EL, Wallace A, Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of perioperative ischemia research group. N Engl J Med 335:1713–1720

    Article  CAS  PubMed  Google Scholar 

  32. Miller DR, Martineau RJ, Wynands JE, Hill J (1991) Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian multicentre trial. Can J Anaesth 38:849–858

    Article  CAS  PubMed  Google Scholar 

  33. POISE Trial Investigators (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371:1839–1847

    Article  Google Scholar 

  34. POISE Trial Investigators, Devereaux PJ, Yang H et al (2006) Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 152:223–230

    Article  Google Scholar 

  35. Poldermans D, Boersma E, Bax JJ et al (2001) Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 22:1353–1358

    Article  CAS  PubMed  Google Scholar 

  36. Poldermans D, Bax JJ, Boersma E et al (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The task force for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 30:2769–2812

    Article  PubMed  Google Scholar 

  37. Poldermans D, Bax JJ, Schouten O et al (2006) Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 48:964–969

    Article  CAS  PubMed  Google Scholar 

  38. Poldermans D, Boersma E, Bax JJ et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341:1789–1794

    Article  CAS  PubMed  Google Scholar 

  39. Poole-Wilson PA, Swedberg K, Cleland JG et al (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial. Lancet 362:7–13

    Article  CAS  PubMed  Google Scholar 

  40. Prys-Roberts C, Foëx P, Biro GP, Roberts JG (1973) Studies of anaesthesia in relation to hypertension V: adrenergic beta-receptor blockade. Br J Anaesth 45:671–681

    Article  CAS  PubMed  Google Scholar 

  41. Raby KE, Brull SJ, Timimi F et al (1999) The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88:477–482

    Article  CAS  PubMed  Google Scholar 

  42. Rinfret S, Abrahamowicz M, Tu J et al (2007) A population-based analysis of the class effect of beta-blockers after myocardial infarction. Am Heart J 153:224–230

    Article  CAS  PubMed  Google Scholar 

  43. Schouten O, Poldermans D, Visser L et al (2004) Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J 148:1047–1052

    Article  CAS  PubMed  Google Scholar 

  44. Sear JW, Giles JW, Howard-Alpe G, Foëx P (2008) Perioperative beta-blockade, 2008: what does POISE tell us, and was our earlier caution justified? Br J Anaesth 101:135–138

    Article  CAS  PubMed  Google Scholar 

  45. Shammash JB, Trost JC, Gold JM et al (2001) Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 141:148–153

    Article  CAS  PubMed  Google Scholar 

  46. Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al (2006) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113:e166–e286

    Article  PubMed  Google Scholar 

  47. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG (1997) Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 33:243–257

    Article  CAS  PubMed  Google Scholar 

  48. Stone JG, Foëx P, Sear JW et al (1988) Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. Br J Anaesth 61:675–679

    Article  CAS  PubMed  Google Scholar 

  49. Urban MK, Markowitz SM, Gordon MA et al (2000) Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 90:1257–1261

    Article  CAS  PubMed  Google Scholar 

  50. Viljoen JF, Estafanous FG, Kellner GA (1972) Propranolol and cardiac surgery. J Thorac Cardiovasc Surg 64:826–830

    CAS  PubMed  Google Scholar 

  51. Wiesbauer F, Schlager O, Domanovits H et al (2007) Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg 104:27–41

    Article  CAS  PubMed  Google Scholar 

  52. Yang H, Raymer K, Butler R et al (2006) The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152:983–990

    Article  CAS  PubMed  Google Scholar 

  53. Yeager MP, Fillinger MP, Hettleman BD, Hartman GS (2005) Perioperative beta-blockade and late cardiac outcomes: a complementary hypothesis. J Cardiothorac Vasc Anesth 19:237–241

    Article  CAS  PubMed  Google Scholar 

  54. Zaugg M, Bestmann L, Wacker J et al (2007) Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block. The Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-control. Anesthesiology 107:33–44

    Article  CAS  PubMed  Google Scholar 

  55. Zaugg M, Tagliente TM, Lucchinetti E et al (1999) Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 91:1674–1686

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Preckel MA, DEAA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preckel, B., Poels, M., Wappler, F. et al. Perioperative β-Rezeptoren-Blockade. Anaesthesist 59, 643–651 (2010). https://doi.org/10.1007/s00101-010-1703-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-010-1703-0

Schlüsselwörter

Keywords

Navigation